Gufic Biosciences Limited (GUFICBIO) — Board Meeting | 14 August 2026 (2 announcements)

Gufic Biosciences announced board approval to incorporate a Philippine subsidiary, Gufic Philippines Inc., to expand pharmaceutical operations and manage IP in the market, with up to USD 250,000 cash investment representing 99.99% ownership.

Gufic Biosciences announced its August 14, 2026 board meeting outcome, approving unaudited Q1 FY27 financial results and incorporating a Philippine subsidiary via $250,000 cash investment. The standalone revenue rose to [amount not verified] from [amount not verified], while consolidated revenue reached [amount not verified]. Net profit stood at [amount context mismatch] crores for the quarter. The new Philippine entity will focus on pharmaceutical distribution and IP management in Southeast Asia.